News
-
-
COMMUNIQUÉ DE PRESSE
Proenkephalin A 119–159 (penKid) Leads the Way in Predicting Graft Outcomes for Kidney Transplant Recipients
Research study reveals Proenkephalin A 119-159 (penKid) as a superior biomarker for predicting kidney transplant outcomes, offering early detection and precise assessment of graft function trajectories -
COMMUNIQUÉ DE PRESSE
DASA, Latin America's Largest Diagnostic Provider, Selects AGFA HealthCare's Enterprise Imaging Platform in Flagship Agreement
AGFA HealthCare's Enterprise Imaging Platform adopted by DASA, Latin America's largest health network. Strategic partnership with Konimagem. Deployment underway for modern, connected care -
COMMUNIQUÉ DE PRESSE
Rapport annuel CEP CAISSE D'EPARGNE BRETAGNE PAYS DE LOIRE EXERCICE 2024
-
-
-
COMMUNIQUÉ DE PRESSE
VVV Resources Limited: Temporary Suspension of trading on Aquis Growth Market pending publication of 2024 Annual Report & Accounts
VVV Resources Limited (VVV) temporarily suspends trading on Aquis Growth Market due to delay in publishing 2024 Annual Report & Accounts. Trading expected to resume soon -
-
-
COMMUNIQUÉ DE PRESSE
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
GenSight Biologics réalise avec succès un placement privé d'un montant de près de 4 millions d'euros pour financer le développememt de LUMEVOQ® et des initiatives réglementaires, tout en honorant les obligations financières